Advertisement
Singapore markets closed
  • Straits Times Index

    3,487.91
    -11.98 (-0.34%)
     
  • S&P 500

    5,647.40
    +16.18 (+0.29%)
     
  • Dow

    40,702.90
    +491.18 (+1.22%)
     
  • Nasdaq

    18,459.89
    -12.67 (-0.07%)
     
  • Bitcoin USD

    64,701.43
    +1,700.14 (+2.70%)
     
  • CMC Crypto 200

    1,340.79
    -0.18 (-0.01%)
     
  • FTSE 100

    8,170.82
    -12.14 (-0.15%)
     
  • Gold

    2,468.60
    +39.70 (+1.63%)
     
  • Crude Oil

    80.82
    -1.09 (-1.33%)
     
  • 10-Yr Bond

    4.1870
    -0.0420 (-0.99%)
     
  • Nikkei

    41,275.08
    +84.40 (+0.20%)
     
  • Hang Seng

    17,727.98
    -287.96 (-1.60%)
     
  • FTSE Bursa Malaysia

    1,625.96
    -3.86 (-0.24%)
     
  • Jakarta Composite Index

    7,224.29
    -54.57 (-0.75%)
     
  • PSE Index

    6,667.09
    -22.28 (-0.33%)
     

Is Vir Biotechnology Stock a Buy?

Is Vir Biotechnology Stock a Buy?

Early in the coronavirus pandemic, Vir Biotechnology's (NASDAQ: VIR) stock rose -- literally and figuratively -- as it joined the list of biotechs looking for vaccines and therapies for the disease. Vir's shares are down by 47% this year alone. This could be a buying opportunity for long-term investors, but only if Vir has enough growth fuel left in the tank.